Eaton Vance Management decreased its position in shares of AptarGroup Inc. (NYSE:ATR) by 3.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 42,159 shares of the company’s stock after selling 1,725 shares during the period. Eaton Vance Management owned 0.07% of AptarGroup worth $3,336,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in ATR. C M Bidwell & Associates Ltd. raised its position in shares of AptarGroup by 16.9% in the first quarter. C M Bidwell & Associates Ltd. now owns 1,555 shares of the company’s stock worth $122,000 after buying an additional 225 shares during the last quarter. Independent Portfolio Consultants Inc. raised its position in shares of AptarGroup by 8.6% in the second quarter. Independent Portfolio Consultants Inc. now owns 2,020 shares of the company’s stock worth $160,000 after buying an additional 160 shares during the last quarter. Fuller & Thaler Asset Management Inc. purchased a new position in shares of AptarGroup during the second quarter worth $174,000. Smith Salley & Associates purchased a new position in shares of AptarGroup during the second quarter worth $210,000. Finally, Fiduciary Management Inc. WI purchased a new position in shares of AptarGroup during the first quarter worth $212,000. Hedge funds and other institutional investors own 88.33% of the company’s stock.

Shares of AptarGroup Inc. (NYSE:ATR) traded down 0.60% during mid-day trading on Wednesday, hitting $78.25. The company’s stock had a trading volume of 129,247 shares. The stock has a 50-day moving average of $77.44 and a 200-day moving average of $77.67. The company has a market cap of $4.92 billion, a PE ratio of 25.41 and a beta of 0.93. AptarGroup Inc. has a 12-month low of $63.62 and a 12-month high of $81.50.

AptarGroup (NYSE:ATR) last posted its earnings results on Thursday, July 28th. The company reported $0.91 EPS for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.01. The company had revenue of $620 million for the quarter, compared to the consensus estimate of $621.52 million. AptarGroup had a return on equity of 16.67% and a net margin of 8.54%. AptarGroup’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.82 earnings per share. On average, equities research analysts forecast that AptarGroup Inc. will post $3.18 EPS for the current year.

A number of research analysts have weighed in on the company. Robert W. Baird raised their price objective on AptarGroup from $80.00 to $84.00 and gave the company a “neutral” rating in a report on Friday, September 9th. BMO Capital Markets restated a “hold” rating on shares of AptarGroup in a report on Friday, September 9th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $76.00.

In other AptarGroup news, insider Salim Haffar sold 50,333 shares of the business’s stock in a transaction on Friday, September 2nd. The stock was sold at an average price of $78.74, for a total transaction of $3,963,220.42. Following the sale, the insider now directly owns 23,149 shares in the company, valued at $1,822,752.26. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Robert Kuhn sold 3,000 shares of the business’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $78.59, for a total value of $235,770.00. Following the sale, the chief financial officer now owns 15,050 shares in the company, valued at $1,182,779.50. The disclosure for this sale can be found here. Company insiders own 5.50% of the company’s stock.

About AptarGroup

AptarGroup, Inc is a provider of a range of packaging, dispensing and sealing solutions, primarily for the beauty, personal care, home care, prescription drug, consumer healthcare, injectables, food and beverage markets. The Company has manufacturing facilities located in North America, Europe, Asia and South America.

5 Day Chart for NYSE:ATR

Want to see what other hedge funds are holding ATR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AptarGroup Inc. (NYSE:ATR).

Receive News & Ratings for AptarGroup Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup Inc. and related companies with MarketBeat.com's FREE daily email newsletter.